Biotech Stock Nearly 300% Sparks Massive Bet on 2027 Breast Drug
A biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
Steer clear of the worst practices in cryptocurrency investing to protect your assets. Learn from common mistakes.
12,710 articlesA biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
When headlines warn of a strike and then show diplomacy's glow, oil markets react in real time. This guide outlines s...
Payoneer’s quarterly results can illuminate how cross-border payments and freelance earnings ecosystems are evolving....
Investors are weighing AI-driven promises against advertising risks as Alphabet and META steer big bets into the futu...
In 2022, the S&P 500 tumbled as inflation hung over markets, but healthcare ETFs held up better. This piece examines ...
A sharp move lower has investors asking if the lululemon stock just 52-week headlines reflect a durable change or a t...
A clear, investor-friendly look at Sonida's Q1 2026 performance. We unpack the numbers, the drivers behind them, and ...
The GTLB story has investors buzzing about whether a rebound is ahead. Even as revenue trends stay strong, the stock ...
SpaceX stock just opened with an eye-catching $150 price, an 11% jump from the IPO price of $135. This article breaks...
What if the driver of Micron’s future isn’t simply more chips, but denser memory in each chip? This article breaks do...
Two AI-era stock stories headline this guide: Palantir as an undervalued growth play and Sandisk as a growth leader w...
Analysts warn AI could disrupt millions of jobs, prompting a national rethink of high school and workforce training. ...